Resources / SAGE documentation

Should CYD-TDV be recommended, over no vaccination, to immunocompetent individuals (≥9 years of age) in dengueendemic countries to mitigate the dengue burden of disease?

Download:

Abstract

Population: Immunocompetent individuals (≥9 years of age)
Intervention: Three doses of CYD-TDV
Comparison(s): No vaccination with CYD-TDV
Outcome: Symptomatic dengue illness, hospitalized dengue and severe dengue

  • Evidence to recommendation table
  • Dengue
Loading...